Download Global Stem Cell Therapy Market Future Outlook Report

Stem cells are specialized cells that can differentiate into other cells without losing their identity. They have been found to be present in animals as well as humans and most of the work has been done on mice. Investigators have found that stem cells are part of repair system and helps in maintaining the normal bodily functions. They divide to give rise to two cells out of which one remains the same while other differentiates into the required cell type. They can replenish throughout the life-time and they could repair damaged organs in order to prevent further damage. They are also influenced by external cues due to which they could be converted into different cell type. It is expected that investigators would be able to make new discoveries that would allow them to assign new properties to stem cells. More research is required in this segment to fully understand the properties of stem cells.

Investigators are trying to decipher stem cells biochemical and biophysical properties so that they could develop them as a therapeutic commodity. Their ability to convert into different cell types could be used for developing regenerative medicines. Organ regeneration at laboratory levels have been achieved but it will take some time for developing fully functional transplantable organ. Investigators have found they could be used for various oncological applications. Modified stem cells could be used for curing cancer and some success has been achieved in past years. Their utility in cardiovascular diseases has been noted as they have ability to regenerate damaged cardiac muscles. In neural disorders like Alzheimer’s disease and Parkinson’s disease their role is being studied as presently available therapeutics have modest efficacy with short-lived effects.

Innovations in pharmaceutical industry seem to be the main driving force for the development of stem cell therapies. Investigators have been able to identify different stem cell sources which offers them large base for developing new therapies. Their customizability and appropriate usage is expected to help them to discover new pharmacological properties that may have high commercialization potential. As a result, large numbers of stem cell therapies are entering in clinical trials across the globe. They are at different stages of development and likely to be introduced in global market in coming years. This will help the stem cell therapy developers to generate significant revenues in coming years. However, this scenario may take few years to materialize but some stem cell therapies have already entered in market which are in clinical practice for past years.

As per recent research report "Global Stem Cell Therapy Market Future Outlook " published by KuicK Research, advancement in stem cell research seems to be increasing continuously across the globe which is apparent from the number of increasing clinical trials. Stem cell therapies for numerous indications are at different stages of clinical trials and they would be introduced in market in coming years. Increased findings and quest for better therapeutics could be considered as main reason behind growth of this segment. Improved technology and development of innovative modalities are further expected to propel the development of stem cell therapies. Only few stem cell therapies have received approval and most of them are small part of forth coming medical revolution. Stem cell therapy developers would be able to generate significant revenues in coming years. In this way, future prospects of stem cell therapies look optimistic and it is expected that more stem cell therapies would be commercialized in coming years.

"Global Stem Cell Therapy Market Future Outlook" Report Highlight:

* Global Stem Cell Market Analysis
* Trends in Stem Cell Research
* Global Stem Cell Market Dynamics: Favorable Factors & Commercialization Challenges
* Global Stem Cell Therapies Clinical Pipeline by Company, Indication & Phase
* Global Stem Cell Therapies in Clinical Pipeline: 114 Therapies
* Majority Stem Cell Therapies in Preclinical Phase: 38 Therapies
* Marketed Stem Cell Therapies Clinical Insight by Brand Name, Company & Indication
* Marketed Stem Cell Therapies Clinical: 2 Therapies (Adipocell® & VesCell™)

For Report Sample Contact: neeraj@kuickresearch.com

Report Weblink: https://www.kuickresearch.com/report-Global-Stem-Cell-Therapy-Market-Future-Outlook.php

1. Introduction to Stem Cells

2. Classification of Stem Cells
2.1 Basis of Ability to Differentiate
2.2 Basis of Origin
2.3 Basis of their Source

3. Different Type of Stem Cell Transplants
3.1 Autologous Stem Cell Transplants
3.2 Allogeneic Stem Cell Transplants
3.3 Syngeneic Stem Cell Transplants

4. Mechanism of Stem Cell Therapy

5. Trends in Stem Cell Research
5.1 Stem Cell Therapy for Cardiovascular Diseases
5.2 Stem Cell Therapy for Cancer Treatment
5.3 Stem Cell Therapy for Central Nervous System Disorders
5.4 Stem Cell Therapy for Ophthalmic Disorders
5.5 Stem Cell Therapy for Metabolic Disorders
5.6 Stem Cell Therapy for Gastrointestinal Diseases

6. Global Stem Cell Market Analysis
6.1 Current Market Scenario
6.2 Global Stem Cell Therapies Pipeline Overview

7. Global Stem Cell Market Dynamics
7.1 Favorable Factors
7.2 Commercialization Challenges

8. Stem Cell Market Future Prospects

9. Global Stem Cell Therapies Clinical Pipeline by Company, Indication & Phase
9.1 Research
9.2 Preclinical
9.3 Clinical
9.4 Phase-I
9.5 Phase-I/II
9.6 Phase-II
9.7 Phase-III
9.8 Registered

10. Marketed Stem Cell Therapies Clinical Insight by Brand Name, Company & Indication
10.1 Adipose Stem Cell Therapy (Adipocell®)
10.2 Angiogenic Cell Precursor Therapy (VesCell™)

11. Discontinued & Suspended Stem Cell Therapies in Clinical Pipeline
11.1 No Development Reported
11.2 Discontinued
11.3 Suspended

12. Competitive Landscape
12.1 Aldagen
12.2 AlloCure
12.3 Anterogen
12.4 Arteriocyte Medical Systems
12.5 Athersys Inc.
12.6 Baxter Healthcare Corporation
12.7 Bioheart
12.8 Cambridge Enterprise Ltd
12.9 Celyad
12.10 Celgene Corporation
12.11 Cellerant Therapeutics
12.12 Cellonis Biotechnologies
12.13 CellPraxis
12.14 Chiesi
12.15 Caladrius
12.16 Cryopraxis
12.17 Cytori Therapeutics
12.18 Gamida Cell
12.19 Genexine
12.20 Geron
12.21 Intrexon Corporation
12.22 K-STEMCELL
12.23 Lifecells LLC
12.24 Medipost
12.25 Medistem Panama
12.26 Mesoblast
12.27 Novartis
12.28 Nuo Therapeutics
12.29 Ocata Therapeutics
12.30 OmniCyte Ltd
12.31 OncoMed
12.32 Osiris Therapeutics
12.33 Pharmicell
12.34 Pluristem Therapeutics
12.35 Promethera Biosciences
12.36 ReNeuron
12.37 Stem Cell Sciences (SCS)
12.38 Stem Cells
12.39 Stemedica Cell Technologies
12.40 TCA Cellular Therapy
12.41 TheraVitae
12.42 TiGenix
12.43 Vericel Corporation

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Kuick Research
New Delhi - 110001
India
+91-11-47067990

This release was published on openPR.